The Top Five "game Changers" in Vaccinology: Toward Rational and Directed Vaccine Development
Overview
Authors
Affiliations
Despite the tremendous success of the classical "isolate, inactivate, and inject" approach to vaccine development, new breakthroughs in vaccine research are increasingly reliant on novel approaches that incorporate cutting edge technology and advances in innate and adaptive immunology, microbiology, virology, pathogen biology, genetics, bioinformatics, and many other disciplines in order to: (1) deepen our understanding of the key biological processes that lead to protective immunity, (2) observe vaccine responses on a global, systems level, and (3) directly apply the new knowledge gained to the development of next-generation vaccines with improved safety profiles, enhanced efficacy, and even targeted utility in select populations. Here we highlight five key components foundational to vaccinomics efforts: applied immunogenomics, next generation sequencing and other cutting-edge "omics" technologies, advanced bioinformatics and analysis techniques, and finally, systems biology applied to immune profiling and vaccine responses. We believe these "game changers" will play a critical role in moving us toward the rational and directed development of new vaccines in the 21st century.
Salod Z, Mahomed O Syst Rev. 2022; 11(1):284.
PMID: 36585703 PMC: 9801145. DOI: 10.1186/s13643-022-02121-0.
Recent developments in systems biology and genetic engineering toward design of vaccines for TB.
Singh Y, Beamer G, Sun X, Shukla P Crit Rev Biotechnol. 2021; 42(4):532-547.
PMID: 34641752 PMC: 11208086. DOI: 10.1080/07388551.2021.1951649.
Rittipornlertrak A, Nambooppha B, Muenthaisong A, Punyapornwithaya V, Tiwananthagorn S, Chung Y PeerJ. 2021; 9:e11765.
PMID: 34316404 PMC: 8288113. DOI: 10.7717/peerj.11765.
Signorazzi A, Pennings J, Etna M, Noya M, Coccia E, Huckriede A Vaccines (Basel). 2021; 9(6).
PMID: 34204532 PMC: 8234070. DOI: 10.3390/vaccines9060664.
Current Challenges in Vaccinology.
Kennedy R, Ovsyannikova I, Palese P, Poland G Front Immunol. 2020; 11:1181.
PMID: 32670279 PMC: 7329983. DOI: 10.3389/fimmu.2020.01181.